腹主动脉瘤腔内修复术后最短贴附长度增加与耐久性改善的多中心分析
这项多中心回顾性观察研究纳入2015至2018年间在荷兰3家高容量医院接受择期EVAR的310例肾下腹主动脉瘤患者,评估首次及末次术后CTA上最短贴附长度(SAL)及其变化对1a型内漏的预测价值。中位随访51个月,SAL增加组无1a型内漏发生,SAL减少组1a型内漏发生率及再干预率更高,作者提出可据此优化影像随访策略。
要点
- SAL增加组5年无1a型内漏生存率100%,稳定组97.1%,减少组81.6%。
- SAL增加组无全类型内漏再干预生存率100%,稳定组84.6%,减少组60.7%。
- 评估近端贴附长度变化或可优化EVAR术后随访风险分层。
核心结论
- 肾下退行性腹主动脉瘤EVAR术后SAL增加是5年内无1a型内漏及无内漏相关二次干预的耐久成功指标。
- SAL减少与EVAR术后1a型内漏发生相关。
- 评估近端贴附长度及其变化可能成为EVAR术后随访的有价值组成部分。
研究设计与样本
- 多中心、回顾性、观察性研究,纳入2015至2018年间在荷兰3家高容量医院连续接受择期EVAR的肾下腹主动脉瘤患者。
- 分析主动脉形态与内移植物位置,在首次术后CTA及可获得的末次CTA上测量最短贴附长度(SAL)。
- 将SAL随时间变化分为增加、稳定、减少三组,与1a型内漏及内漏二次干预进行相关性分析,采用Kaplan-Meier分析计算无1a型内漏生存率及无再干预生存率。
主要发现
- 共纳入310例腹主动脉瘤患者,中位随访51个月(Q1 17,Q3 71)。
- 首次术后CTA上SAL中位值为22.8 mm(Q1 15.9,Q3 30.4)。
- 310例中168例(54%)有第二次术后CTA,其中71例(42%)SAL随时间增加;SAL增加组无1a型内漏发生,稳定组43例中1例(2%)发生,减少组54例中10例(19%)发生。
- EVAR术后5年无1a型内漏生存率:增加组100%,稳定组97.1%(p=0.195),减少组81.6%(p<0.001)。
- 无全类型内漏再干预生存率:增加组100%,稳定组84.6%(p<0.001),减少组60.7%(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular aortic repair (EVAR) for an aneurysm of the abdominal aorta (AAA) is associated with long-term complications, such as endoleaks, resulting in a significant re-intervention rate. This study investigates the prognostic value of (change of) proximal seal length on post-EVAR computed tomography angiography (CTA) for predicting type 1a endoleak. It further proposes a risk-stratified imaging follow-up algorithm. DESIGN: Multicentre, retrospective, observational study of consecutive patients who underwent elective EVAR for infrarenal AAA between 2015 and 2018 at 3 high-volume hospitals in the Netherlands. MATERIALS AND METHODS: Aorta morphology and endograft position analysis was performed. Shortest apposition length (SAL) was measured on the first post-EVAR CTA and, if available, on the last CTA. Change of SAL through time was categorized as increasing, stable, or decreasing and correlated with type 1a endoleak and secondary interventions for endoleak. Kaplan-Meier analysis was used to calculate type 1a endoleak free and re-intervention-free survival. RESULTS: Three hundred ten AAA patients with a median follow-up of 51 (Q1, 17; Q3, 71) months were included. A median SAL of 22.8 mm (Q1, 15.9; Q1, 30.4) was measured on the first post-EVAR CTA. In 168 of 310 patients (54%), a second post-EVAR CTA was available, in which 71 (42%) showed increasing SAL over time. No type 1a endoleak developed in the increasing SAL group, whereas 1 of 43 (2%) in the stable group and 10 of 54 (19%) in the decreasing group developed type 1a endoleak. Five years post-EVAR, type 1a endoleak-free survival was 100% in the increasing SAL group versus 97.1% in the stable SAL group (p=0.195), and 81.6% in the decreasing SAL group (p<0.001). The re-intervention for all types of endoleak-free survival was 100% in the increasing SAL group versus 84.6% in the stable SAL group (p<0.001), and 60.7% (p<0.001) in the decreasing SAL group. CONCLUSION: Increasing SAL after EVAR for infrarenal degenerative AAA is an indicator of durable success without type 1a endoleak and endoleak-associated secondary intervention within 5 years. Decreasing SAL is associated with development of type 1a endoleak after EVAR. Evaluation of (change of) the proximal seal could be a valuable part of follow-up after EVAR.Clinical ImpactEvaluation of proximal seal length after endovascular aortic repair offers valuable prognostic information regarding the risk of type 1a endoleak. Implementation could refine current follow-up algorithms to better stratify patients who have a substantial risk of type Ia endoleak from patients who may benefit from limited image surveillance.
引用
- Hendricks CHF, Schuurmann RCL, Fioole B, et al. Improved Endovascular Aortic Repair Durability in Patients Achieving Increased Shortest Apposition Length: A Multi-Centre Analysis. J Endovasc Ther. 2025. PMID: 40357763. doi:10.1177/15266028251338812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。